Company Overview of Bio-Life Labs Inc.
Bio-Life Labs, Inc. engages in the discovery, development, and commercialization of treatments for cancer, diabetes mellitus, hepatitis C. It holds worldwide license for Carcinoderm, an ointment that can be used to treat skin cancer patients with basal cell carcinoma, squamous cell carcinoma, and melanoma. The company is headquartered in Phoenix, Arizona.
2425 East Camelback Road
Phoenix, AZ 85016
Key Executives for Bio-Life Labs Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Bio-Life Labs Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.